Journal of Chemotherapy

Article	Citations
Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis	70
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam	48
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA2	31
Innovative sequential therapy in a rare case of refractory Erdheim-Chester disease with bilateral pulmonary involvement	30
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer	22
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem	21
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae	17
Cytofluorimetric study of cerebrospinal fluid at staging of diffuse large B cell lymphoma	13
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis	13
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer	12
YAP/TAZ axis was involved in the effects of metformin on breast cancer	12
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database	11
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients	10
Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin	9
Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study	9
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics	9
Combination therapy of sotorasib and docetaxel overcomes resistance to sotorasib alone in KRAS G12C mutant lung adenocarcinoma	9
Causative agents of bloodstream infections in two Croatian hospitals and their resistance mechanisms	9
Reevaluating immunotherapy’s potential in first-line metastatic urothelial carcinoma	9
A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic cours	8
The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade	8
Early daratumumab-based therapy demonstrates significant effectiveness in patients with relapsed and refractory multiple myeloma: a real-world retrospective investigation	8
The pharmacokinetics of ganciclovir during prolonged intermittent kidney replacement therapy in a cardiac transplant recipient	8
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma	8
Relationship between the change in tumour-infiltrating lymphocyte level and residual tumour after neoadjuvant chemotherapy in patients with locally advanced breast cancer	8

Reversible chemoresistance of pancreatic cancer grown as spheroids	8
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals	8
Developing new drugs for adult T-cell leukemia/lymphoma by targeting hypoxia: insights from toxicity of MS-275 and its analogs	8
Recent advances in polymer-based nanoparticles: current strategies and translational challenges in cancer therapy	7
Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience	7
Advances in MUC1 resistance to chemotherapy in pancreatic cancer	7
Exploring the role of quercetin on doxorubicin and lapatinib-mediated cellular and mitochondrial responses using in vitro and in s	7
Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer	7
Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status	7
The role of maintenance therapy in the treatment of advanced urothelial cancer: a comprehensive systematic review and network meta-analysis	7
Clinical benefit of PD-1/PD-L1 inhibitors for poor performance status patients with advanced non-small cell lung cancer	7
Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital	7
In vitro killing of multidrug/extensively drug-resistant Pseudomonas aeruginosa by fosfomycin alone or in combination with antipseudomonal antibiotics	7
Genetic landscape and therapeutic evolution of cyclophosphamide: spotlight on breast cancer	7
Impact of clinical pharmacist’s interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention study	6
Initial cumulative area under the blood concentration-time curve of vancomycin is associated with the incidence of acute kidney injury	6
Emerging role of competing endogenous RNA in lung cancer drug resistance	6
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells	6
A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer	6
Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway	6
Cost-effectiveness analysis of dostarlimab plus chemotherapy versus pembrolizumab plus chemotherapy as first-line treatment of metastatic non-squamous non-small cell lun	6
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story	5
E2F1-induced transcriptional activation of MAL2 inhibits sunitinib sensitivity and promotes the malignant progression of bladder cancer	5
Novel SNX25-ROS1 fusion mutation confers therapeutic sensitivity to entrectinib: a case report and literature review	5
Short-term neurotoxicity trajectory in patients with thoracic cancers receiving triweekly albumin-bound paclitaxel	5
Erythema multiforme as a rare skin manifestation during pembrolizumab treatment: a case report and literature review	5
Comparison of Syrian generic ceftriaxone sodium preparations for injection: BHT content and its implications	5
LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma	5
Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia	5
A case of ICIs-associated arthritis caused by Toripalimab initially presenting as oedema in both lower limbs	5
Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin	4
In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae<	4
Successful treatment with oxaliplatin and programmed cell death protein 1 inhibitor in recurrent advanced endometrial carcinoma with mismatch repair defects: a case report and literature review	4
Furmonertinib activity in NSCLC Harbouring EGFR L858R and ERBB2 S310F co-mutations: a case report with literature review	4
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine	4
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells	4
Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza	4
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey	4
Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials	4
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study	4
Evaluation of in vitro activity of ceftaroline, ceftobiprole and their combination with trimethoprim/sulfamethoxazole against MRSA isolates: a two center study	4
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes	4
Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes in breast cancer patients: a systematic review study	4
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses	4
Impact of ward pharmacist-led antimicrobial stewardship in intensive care units	4
Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report	4
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma	4
Biliary disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database	4
The tumor microenvironment: shaping cancer progression and treatment response	4
Neurological toxicities with poly (ADP-ribose) polymerase inhibitors in cancer patients: a systematic review and meta-analysis	4

Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations	4
Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemia	4
Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer	3
Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience	3
Prognostic significance of pyrimidine metabolism-related genes as risk biomarkers in hepatocellular carcinoma	3
Fixed-dose antiretroviral combinations in children living with human immunodeficiency virus type 1 (HIV-1): a systematic review	3
Case series of metastatic breast cancer patients with visceral crisis treated with CDK4/6 inhibitors	3
Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma	3
Liposome-assisted combination chemotherapy improves the anti-proliferation and anti-angiogenesis response of cisplatin in breast cancer; experimental and computational study	3
Prognostic and immunological values of SKA3 for overall survival in lung adenocarcinoma and its RNA binding protein involved mechanisms	3
Clinical features, treatments, and outcomes of atezolizumab-induced diabetes mellitus in cancer patients	3
Assessment of in vitro interactions between delafloxacin and other antimicrobials against multi-drug resistant Pseudomonas aeruginosa strains	3
Time to reconsider moxifloxacin anti-anaerobic activity?	3
Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression	3
Docetaxel associated myositis	3
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital	3
Cost-effectiveness analysis of pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer	3
LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p/PPP2R1B signalling pathway	3
Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways	3
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge	3
Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients	3
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy	3
Implementation of effective strategies to prevent Candida auris transmission in a Quaternary Care Center, Riyadh, Saudi Arabia	3
Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis	3
Long-term outcomes of sequential chemotherapy in epithelioid sarcoma	3
NCAPG2 promotes the proliferation, metastasis and resistance to nab-paclitaxel in gastric adenocarcinoma cells	3
Varicella zoster virus reactivation reported with isatuximab use	3
A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant Klebsiella pneumoniae	3
CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner	3
Colistin resistance among the Gram-negative nosocomial pathogens in India: a systematic review and meta-analysis	3
STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy	3
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2	3
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco)	3
Postmarket review of photosensitivity associated with select BRAF and MEK inhibitors	2
Timing of chemotherapy after diagnosis of small cell lung cancer	2
USP54 suppresses bladder cancer proliferation, stemness, and cisplatin resistance via deubiquitination-mediated stabilization of SIRT6	2
Aminoglycoside antibiotics as first-line treatment of acute appendicitis and cholecystitis	2
Intraperitoneal daptomycin dosing for peritonitis may be inadequate: a Monte Carlo simulation approach to optimize dosing and outcomes	2
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis	2
Comparison of the prognostic effect of pyrotinib plus trastuzumab and chemotherapy different lines therapy in HER2-positive advanced breast cancer	2
Rethinking antibiotic use in hidradenitis suppurativa: a call for stewardship	2
Identification of T cell-related biomarkers for breast cancer based on weighted gene co-expression network analysis	2
Establishing and characterizing a novel doxorubicin-resistant acute myeloid leukaemia cell line	2
Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy	2
Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and in vitro cytotoxicity study against human HepG2 carcinoma cells	2
Management of hereditary hemorrhagic telangiectasia-like symptoms induced by trastuzumab emtansine in a breast cancer patient: case report	2
Efficacy of pembrolizumab in patients with chemotherapy-resistant gestational trophoblastic neoplasia, a case report	2
The gene-panel obtained by anti-PD-1 monotherapy for melanoma reveals prognostic markers and therapeutic targets	2
LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis	2
Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant Staphylococcus aureus bloodstream infections: a case series and literature r	2
Real-world effectiveness and safety of meropenem–vaborbactam in the treatment of carbapenem-resistant enterobacterales (CRE) infections: a systematic review and meta-analysis	2
Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia	2
Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients	2
Upregulation of apoptotic genes and downregulation of target genes of Sonic Hedgehog signaling pathway in DAOY medulloblastoma cell line treated with arsenic trioxide	2
Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective study	2
Transcriptional factor KLF9 overcomes 5-fluorouracil resistance in breast cancer via PTEN-dependent regulation of aerobic glycolysis	2
Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway	2
Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced	2
Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian, peritoneal, or fallopian tube cancer: a retrospective observational study	2
Study on the clinical efficacy of 14-day vonoprazan-based triple regimen in obese patients with Helicobacter pylori infection	2
Exposure-response analyses of pemigatinib in patients with myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement	2
Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis	2
Tigecycline treatment causes a decrease in peripheral blood platelet	2
Antiviral drug resistance in cytomegalovirus complicating hematopoietic stem cell transplantation: prevalence, genotypic analysis and novel UL97/UL54 var	2
Disseminated intravascular coagulation (DIC) associated with immune checkpoint inhibitor therapy: a real-world study of the FDA adverse event reporting system	2
Effects of anthracyclines on arteriosclerosis and the protective effect of dexrazoxane in breast cancer patients	2
Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability	2
LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis	2
Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus , Streptococcus pneumoniae and	2
Mpox: there is still risk of global outbreak	2
Statement of Retraction: Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line	2
Retrospective analysis of risk factors for levofloxacin-induced liver injury	2
Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting	2
Camrelizumab-induced anaphylactic reaction: a case report and literature review	2
Clinical scoring model for predicting cefotaxime-resistance in Klebsiella pneumoniae bacteremia: development and validation based on portal of entry	1
Eribulin in metastatic breast cancer in the real-world - the way forward in the Indian setting	1
Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG)	1
In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation	1
Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study	1
Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis	1

Unilateral facial nerve paralysis following prolonged weekly paclitaxel therapy: a rare case of cranial neurotoxicity with diagnostic challenges	1
Investigation of chemotherapy-induced cardiac dysfunction in breast cancer	1
Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives	1
Durable pembrolizumab response in metastatic MSS ARID1A-mutant undifferentiated carcinoma of the esophagus	1
Influencing factors of acute severe to very severe peripheral neuropathy induced by albumin-bound paclitaxel	1
Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis	1
PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer in vitro and in vivo	1
PqsR-specific quorum sensing inhibitors targeting Pseudomonas aeruginosa : current advances and future directions	1
Pembrolizumab associated immune thrombocytopenia	1
Pharmacokinetic parameters of CAZ–AVI in the normal lung and in models of pneumonia: lessons for treatment optimization in critical care	1
Integrating immunotherapy into chemotherapy: real-world efficacy of GEMOX plus Tislelizumab in advanced gallbladder cancer	1
Therapy-related hand-foot syndrome: a review	1
Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review	1
Application of dihydropyrimidine dehydrogenase deficiency testing for the prevention of fluoropyrimidine toxicity: a real-world experience in a Southern Italy cancer center	1
Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells	1
Characterizing pulmonary adverse events associated with the immune checkpoint inhibitor avelumab: a FAERS-based pharmacovigilance study from 2013 to 2024	1
Efficacy and safety of veliparib in the treatment of advanced/metastatic breast cancer: a meta-analysis of phase II and III randomized controlled trials	1
Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model	1
Adjuvant chemotherapy for elderly patients with colorectal cancer: a single-centre observational study in Japan	1
Successful remdesivir treatment of coronavirus OC43 pneumonia in a lung transplant recipient	1
VEGF-A splicing variant in plasma is a predictive potential biomarker of bevacizumab in advanced non-squamous non-small cell lung cancer	1
Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer	1
A network between infectious diseases department and general practitioners for COVID-19 patients: towards a strengthened link?	1
Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins	1
Therapeutic drug monitoring-guided high-dose isavuconazole therapy for invasive pulmonary aspergillosis in a patient on extracorporeal membrane oxygenation support	1
Blocking lncRNA HCG18 re-sensitizes Taxol resistant lung cancer cells to Taxol through modulating the miR-34a-5p/HDAC1 axis	1
MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer	1
Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment	1
Assessing the prevalence and severity of cisplatin-induced nephrotoxicity in a minority- low socioeconomic population in the Bronx, New York	1
Neural networks for the prediction of bacterial and fungal infections: current evidence and implications	1
Mpox vaccination and treatment: a systematic review	1
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study	1
Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension	1
Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass	1
Enhanced synergy of pacritinib with temsirolimus and sunitinib in preclinical renal cell carcinoma model by targeting JAK2/STAT pathway	1
Long-term remission after upfront autologous hematopoietic stem cell transplant for CD5 + diffuse large-B cell lymphoma	1
Efficacy and safety of trastuzumab deruxtecan in HER2-high and HER2-low breast cancer: a systematic review and meta-analysis of randomized controlled trials	1
Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort	1
A new chemotherapy strategy for advanced hepatocellular carcinoma with exrahepatic metastasis: predictors of long-term survival	1
Elevated CK from immune checkpoint inhibitor- related hypophysitis: a case report	1
Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer	1
TRIM24/ZFX affects the stemness and resistance to 5-FU of colorectal cancer cells	1
LncRNA-FGD5-AS1 promotes 5-Fu resistance of cervical cancer cells through modulating the miR-130a-3p-YTHDF2 axis	1
Efflux pump effects on Mycobacterium tuberculosis drug resistance	1
microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2	1
Analysis of risk factors for infusion-related reactions in patients with B-cell lymphoma during obinutuzumab treatment	1
Dose dependent nanoparticle albumin bound paclitaxel + pembrolizumab alters the immune micro environment in a esophageal homograft mouse model	1
Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy	1
The efficacy and safety analysis of oral isavuconazole therapy of invasive pulmonary aspergillosis	1
Mpox outbreak in a cluster of hospitals at Riyadh, Saudi Arabia 2022–2023: clinical presentation, risk factors, and preventive measures	1
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing	1
Determination of survival associated genetic biomarkers to discover novel therapeutic targets for acute myeloid leukaemia	1
Cinobufagin regulates the microRNA-149-3p/AFF4 axis to affect the proliferation and apoptosis of cisplatin-resistant ovarian cancer cells	1
Tumor mutational burden in non-immunotherapy patients with heavily pretreated metastatic breast cancer: long-term outcomes from a single institution	1
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.	1
Atorvastatin attenuates intestinal mucositis induced by 5-fluorouracil in mice by modulating the epithelial barrier and inflammatory response	1
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study	1
Safety of Sotrovimab use in children with COVID-19: an Italian experience	1
CircRNA_0044556 affects the sensitivity of triple-negative breast cancer cells to paclitaxel by regulating miR-665	1
Self-assembled redox-responsive BRD4 siRNA nanoparticles: fomulation and its in vitro delivery in gastric cancer cells	1
Alternatives for the administration of oral antineoplastics in patients with swallowing difficulties	1
The crucial relationship between vancomycin minimum inhibitory concentration and therapeutic efficacy against methicillin-resistant coagulase-negative staphylococci	1
An acquired CCDC6:: RET gene fusion as resistance mechanism for Osimertinib in exon 21 EGFR(L858R) -mutate	1